The human cytomegalovirus (HCMV) glycoproteins H and L (gH/gL) can be bound by either gO, or the UL128-36 131 proteins to form complexes that facilitate entry and spread and the complexes formed are important 37 targets of neutralizing antibodies. Strains of HCMV vary considerably in the levels of gH/gL/gO and 38 gH/gL/UL128-131 and this can impact infectivity and cell tropism. In this report, we investigated how natural 39 interstrain variation in the amino acid sequence of gO influences the biology of HCMV. Heterologous gO 40 recombinants were constructed in which 6 of the 8 alleles or genotypes (GT) of gO were analyzed in the 41 backgrounds of strain TR and Merlin (ME). The levels of gH/gL complexes were not affected, but there were 42 impacts on entry, spread and neutralization by anti-gH antibodies. AD169 (AD) gO (GT1a) drastically reduced 43 cell-free infectivity of both strains on fibroblasts and epithelial cells. PHgO(GT2a) increased cell-free infectivity 44 of TR in both cell types, but spread in fibroblasts was impaired. In contrast, spread of ME in both cell types 45 was enhanced by Towne (TN) gO (GT4), despite similar cell-free infectivity. TR expressing TNgO(GT4) was 46 resistant to neutralization by anti-gH antibodies AP86 and 14-4b, whereas ADgO(GT1a) conferred resistance 47 to 14-4b, but enhanced neutralization by AP86. Conversely, ME expressing ADgO(GT1a) was more resistant 48 to 14-4b. These results suggest; 1) mechanistically distinct roles for gH/gL/gO in cell-free and cell-to-cell 49 spread, 2) gO isoforms can differentially shield the virus from neutralizing antibodies, and 3) effects of gO 50 polymorphisms are epistatically dependent on other variable loci.
INTRODUCTION
recently reported that HCMV BAC-clones can sustain various genetic deletions, and rearrangements, and 45 mutations during rescue in fibroblasts or epithelial cells, resulting in mixed genotype populations (52). To 46 ensure that phenotypes characterized were the associated with the intended changes to UL74(gO) and not to 47 other genetic changes sustained during BAC rescue in fibroblasts, all analyses were performed on at least 48 three independently BAC-rescued viral stocks.
49
As a basis for interpretation of the later biological comparisons among recombinants, the levels of 50 gH/gL complexes incorporated into the virion envelope were analyzed by immunoblot as previously described 51 (9, 26) . As in the previous reports, TR contained predominantly gH/gL/gO, whereas ME contained mostly 52 gH/gL/UL128-131 (Fig 1, compare lane 1 in panels A and B). Propagation of ME under conditions of UL131 53 transcriptional repression (denoted "Merlin-T" (MT) as described (26, 51) ), resulted in more gH/gL/gO and less 54 gH/gL/UL128-131 (Fig. 1C, lane 1) . Some minor differences in the amounts of total gL, gH/gL/gO, and 55 gH/gL/UL128-131 were observed for some of the heterologous gO recombinants relative to their parental 56 strains. However, band density analyses showed that all apparent differences were less than 3-fold and few 57 reached statistical significance when compared across multiple experiments, likely reflecting the limitations of 58 immunoblot as a precise quantitative method, as well as stock-to-stock variability in glycoprotein composition 59 (Table 1) . Thus, consistent with our previous report, differences between strains TR and ME in the abundance 60 of gH/gL complexes are predominately influenced by genetic background differences outside the UL74(gO) effect of each heterologous gO was similar to that observed on fibroblasts ( Fig 3A, bottom panel) . Thus, some preferences reported in Figure 2A .
00
The infectivity of cell-free ME virions on both cell types was below the detection limit of the flow 01 cytometry-based assay and none of the changes to gO rescued infectivity ( Fig 3B) . These results indicated 02 that the cell-free virions of all of the ME-based viruses were virtually non-infectious. When propagated as MT, 03 infectivity on both cell types was improved to levels comparable to TR and this was consistent with our 04 previous results ( Fig 2C) (26, 48) . The only significant effect of gO changes on MT was ADgO(GT1a), which 05 reduced infectivity on both cell types,. Thus, as in the TR background, some changes to gO influenced 06 infectivity of MT and this was disproportionally manifest on fibroblasts compared epithelial cells, but the overall 07 preference of all of the MT-based viruses was strongly in favor of fibroblasts. In contrast, gO changes had little 08 effect on the infectivity or tropism of ME-based viruses.
09
It has been reported that gO-null HCMV are impaired for attachment to cells and that soluble gH/gL/gO 10 can block HCMV attachment (33, 54). Thus, it was possible that the observed changes to cell-free infectivity 11 due to gO polymorphisms were related to a role for gO in attachment. To test this hypothesis, each 12 heterologous gO recombinant was compared to the corresponding parental strain by applying cell-free virus 13 stocks to fibroblast or epithelial cell cultures for approximately 20 min, washing away the unbound virus and 14 then counting the numbers of cell-associated virions by immunofluorescence staining of the capsid-associated 15 tegument protein pp150 (33) (Fig 4 and Tables 2 and 3 ). Given the short incubation time, high concentrations 16
of input viruses were used to, and these inputs were equal for each set of parental and heterologous gO 17 recombinants within the constraints of the stock concentrations. Higher inputs were required for ME to obtain 18 detectable numbers of bound virus, consistent with the low amounts of gH/gL/gO in these virions. The average 19 number of cell-associated virions per cell varied considerable between experiments, likely reflecting the 20 complex parameters expected to influence virus attachment including stock concentration, cell state and 21 variability in the incubation time between experiments. In some cases, a given recombinant was significantly 22 different from parental in only one or two of the three experiments. It was concluded that these specific gO 23 isoforms did not affect binding or attachment of HCMV to cells. However, binding of TR_TNgO(GT4) and 24 MT_ADgO(GT1a) were each significantly lower than their respective parental viruses in all three experiments 25 on both fibroblasts and epithelial cells. While it was possible that the reduced binding of MT_ADgO(GT1a) was TR_TNgO(GT4) could not be similarly explained since this virus had slightly more gH/gL/gO than the parental 28 TR ( Fig. 1A , Table 1 ). Moreover, reduced binding may help explain the lower infectivity of MT_ADgO(GT1a) 29 ( Fig 3C) , but the poor infectivity of TR_ADgO(GT1a) could not be explained by poor binding, and the reduced 30 binding of TR_TNgO(GT4) did not result in reduction of infectivity ( Fig 3A) .
31
In sum, these analyses indicated that; 1) gO polymorphisms can influence the cell-free infectivity of 32 HCMV. In some cases this was independent of any effects on abundance of gH/gL/gO in the virion envelope 33 or binding to cells (e.g. parental TR and TR recombinants harboring MEgO(GT5), TBgO(GT1c), and 34 ADgO(GT1a), had dramatically different infectivity but comparable levels of gH/gL/gO and cell binding). 2) The
35
influence of some gO isoforms was dependent on the background strain (e.g., PHgO(GT2a) enhanced TR 36 infectivity but did not affect ME or MT and TNgO(GT4) reduced binding of TR but had no effect on binding of 37 ME or MT). 3) While some heterologous gO recombinants had quantitatively different effects on infectivity on 38 fibroblast compared to epithelial cells, these did not change the fundamental fibroblast preferences for either 39 TR or MT. 4) Some of the heterologous gOs did appear to change relative tropism of ME. However, the 40 relevance of tropism ratios for these viruses is questionable since the specific infectivity (genomes/IU)
41
analyses suggested that all ME-based recombinants were noninfectious on either cell type. This was 42 consistent with the highly cell-associated nature of ME (50, 51) . 43
Polymorphisms in gO can differentially influence the mechanisms of cell-free and cell-to-cell 44 spread. The analyses described above focused on the cell-free infectivity of HCMV, as indicative of a cell-free 45 mode of spread. Cell-to-cell spread mechanisms are likely important for HCMV, and while gH/gL complexes 46 are clearly important for cell-to-cell spread, the mechanisms in these processes are poorly characterized in comparison to cell-free infection. Strains TR and ME are well-suited to compare the effects of gO 48 polymorphisms on cell-free and cell-to-cell spread since ME is mostly restricted to cell-to-cell due to the poor 49 infectivity of cell-free virions but can be allowed to also spread cell-free by propagation as MT, whereas TR can 50 spread by both cell-free and cell-to-cell mechanisms (23, 26, 50, 51) . 51
To compare spread among heterologous gO recombinants, replicate cultures were infected at low 52 multiplicity, and at 12 dpi, foci morphology was documented by fluorescence microscopy and the increased 53 number of infected cells was determined by flow cytometry. In fibroblasts cultures, parental TR and MT showed more diffuse foci compared to the tight, localized focal pattern of parental ME, consistent with the notion that TR and MT spread by both cell-free and cell-to-cell mechanisms whereas ME was restricted to cell-56 to-cell spread ( Fig 5A) . Quantitatively, spread by parental TR increased the numbers of infected cells 55-fold 57 over 12 days, whereas spread of TR_MEgO(GT5) and TR_PHgO(GT2a) were significantly reduced ( Fig 5B) .
58
Spread of ME was slightly reduced by ADgO(GT1a), but was increased by TNgO(GT4) ( Fig 5C) . Surprisingly, 59 different effects on spread were observed for MT where TBgO(GT1c) and TNgO(GT4) reduced spread, and 60 ADgO(GT1a) increased spread.
61
A number of interesting incongruities were observed when comparing the cell-free infectivity of some 62 gO recombinants on fibroblasts to their respective spread characteristics in fibroblasts; 1) Spread of TR_PHgO 63 in fibroblasts was reduced compared to the parental TR ( Fig 5B) , but the cell-free infectivity of this recombinant 64 was actually better ( Fig 3A) . Similarly, spread of both MT_TBgO(GT1c) and MT_TNgO(GT4) were reduced in 65 fibroblasts ( Fig 5D) , but cell-free infectivity of both viruses was comparable to parental MT. 2) Conversely,
66
MT_ADgO(GT1a) spread better in fibroblasts ( Fig 5D) , but the cell-free infectivity was substantially worse (Fig   67   3C ). Since the efficiency of cell-free spread should depend on both the specific infectivity and the quantities of 68 progeny virus released to the culture supernatants, it was possible that some of these incongruities reflected 69 offsetting differences in the quantity of cell-free virus released as compared to their infectivity. To test this, 70 progeny released from infected fibroblasts into culture supernatants were quantified by qPCR. There were no 71 significant differences in the quantity of progeny released per cell for any of the TR or ME-based recombinants 72 ( Fig. 6A, and B ). Likewise, all of MT-based recombinants released similar numbers of cell-free progeny except 73 for MT_ADgO(GT1a), which was reduced by approximately 4-fold ( Fig. 6C ). Thus, the discrepancies between 74 efficiency of spread and cell-free infectivity could not be explained by offsetting differences in the release of 75 cell-free progeny. Rather, these results suggested that gO polymorphisms can differentially influence the 76 mechanisms of cell-free and cell-to-cell spread in fibroblasts. The interpretation that gH/gL/gO can provide a 77 specific function for cell-to-cell spread was supported by the results that expression of ADgO(GT1a) and 78 TNgO(GT4), respectively reduced and increased spread of the strain ME, for which spread is almost 79 exclusively cell-to-cell ( Fig 5C) .
80
Spread was also analyzed in epithelial cell cultures. Here, foci of both TR and ME remained tightly 81 localized, suggesting predominantly cell-to-cell modes of spread for both strains in this cell type (Fig. 7A ). The previously and may relate to the low expression of gH/gL/UL128-131 by TR compared to ME (23, 26, 55) . 85
Expression of TNgO(GT4) further reduced TR spread in epithelial cells ( Fig 7B) . In contrast, ME spread was 86 slightly reduced by TBgO(GT1c) and ADgO(GT1a), but nearly doubled by TNgO(GT4). The observed increase 87 in ME spread due to TNgO(GT4) was not attributed to increased release of progeny to the culture supernatants 88 in epithelial cells (Fig 8) . Note that spread of MT could not be addressed in epithelial cells, since the contribution of gO polymorphisms (23). Nevertheless, it is clear from these experiments that gO 91 polymorphisms can affect spread in epithelial cells and that this can depend on the background strain.
92
Specifically, TNgO(GT4) reduced TR spread but increased ME spread. This suggested that although 93 gH/gL/UL128-131 is required for efficient cell-to-cell spread in epithelial cells, and may even be sufficient in the 94 case of gO-null HCMV (25, 27), gH/gL/gO may also contribute to the mechanism when present. 95
Polymorphisms in gO can affect antibody neutralization on gH epitopes. The extensive N-linked 96 glycosylation of gO raised the possibility that gO could present steric hindrance to the binding of antibodies to 97 epitopes on gH/gL, as was shown for HCMV gN and also HIV env (44, 45) . A corollary hypothesis was that 98 such effects might vary with the polymorphisms among gO isoforms. To address this, neutralization 99 experiments were conducted using two monoclonal anti-gH antibodies; 14-4b, which recognizes a 00 discontinuous epitope likely located near the membrane proximal ectodomain of gH (35, 56) and AP86, which 01 binds to a continuous epitope near the N-terminus of gH (57). Note that these experiments could only be 02 performed with TR-and MT-based recombinants since the cell-free progeny of ME-based viruses were found 03 to be only marginally infectious ( Fig 3B) .
04
Parental TR and recombinants encoding MEgO(GT5), PHgO(GT2a) and TBgO(GT1c) were 05 completely neutralized on fibroblasts by mAb 14-4b, whereas TR_ADgO(GT1a) and TR_TNgO(GT4) were 06 significantly resistant ( Fig 9A) . There was more variability among TR-based recombinants with mAb AP86 (Fig   07   9B ). Here, parental TR could only be neutralized to approximately 40% residual infection. TNgO(GT4) recombinants ( Fig 9C, and D) . This was consistent with the interpretation that both 14-4b and AP86 could bind 12 their epitopes on gH/gL/UL128-131 and that this represented the majority of the observed neutralization on 13 epithelial cells. However, TR_TNgO(GT4) still displayed some reduced sensitivity to both antibodies, 14 suggesting that gH/gL/gO epitopes also contributed to neutralization on epithelial cells.
15
MT-based recombinants were generally more sensitive to neutralization by 14-4b than were TR-based 16 viruses (compare 14-4b concentrations in Fig 9A and 10A) . Strikingly, whereas TNgO(GT4) conferred 14-4b 17 resistance to TR, it did not in MT, and instead ADgO(GT1a) provided resistance to 14-4b ( Fig 10A) . As was 18 observed for TR-based recombinants, 14-4b neutralization on epithelial cells was less affected by gO 19 polymorphisms ( Fig 10B) . Note that neutralization of MT-based recombinants by AP86 could not be tested 20 since MEgH harbors a polymorphism in the linear AP86 epitope that precludes reactivity (57). Together, these 21 results indicated that differences among gO genotypes can differentially affect antibody neutralization on gH 22 epitopes. Moreover, which gO genotype could protect against which antibody depended on the background 23 strain, suggesting the combined effects of gO polymorphisms and gH/gL polymorphisms.
24

DISCUSSION
25
Efficient cell-free infection of most, if not all cell types requires gH/gL/gO (22, 25, 26) . However, the 26 details of the mechanisms, and the distinctions between the roles of gH/gL/gO in cell-free and cell-to-cell 27 spread remain to be clarified. While there are naturally occurring amino acid polymorphisms in each subunit of 28 gH/gL/gO, gO has the most dramatic variation, with 8 known genotypes (or alleles) that differ between 10-30% 29 of amino acids (9-12). All isoforms of gO are predicted to have extensive N-linked glycan modifications and 30 some of the amino acid differences alter the predicted sites. In a previous report, we sought to determine if gO 31 polymorphisms were a factor influencing the different levels of gH/gL/gO and gH/gL/UL128-131 in strains TR 32 and ME. On the contrary, results suggested that genetic differences outside the UL74(gO) ORF result in more 33 rapid degradation of gO in the ME-infected cells compared to TR, and this influences the pool of gO available 34 during progeny assembly (48). Kalser et al. reported that gO polymorphisms could differentially affect multi-35 step replication kinetics in fibroblasts and epithelial cells (49). However, only TB was analyzed as the 36 background and distinctions between effects on cell-free and cell-to-cell spread were unclear. In this report we 37 constructed a matched set of heterologous gO recombinants in the well-characterized, BAC-cloned strains TR neutralization by anti-gH antibodies. The results demonstrate that gO polymorphisms can influence each of 40 these parameters and the effects in some cases were dependent on the genetic background, suggesting a 41 number of possible epistatic phenomena at play.
42
A commonly used measure to assess the tropism of HCMV strains, isolates and recombinants is the 43 ratio of infection between fibroblasts and other cell types, including epithelial and endothelial cells (49, 55, 58, 44 59 ). Expressions of this ratio have varied, but have generally involved a normalization of the epithelial or 45 endothelial infection to that of fibroblasts. Here we similarly determined the infectious titer of each of the 46 parental strains and heterologous gO recombinants on both fibroblasts and epithelial cells and expressed ratios ≥1 (either fibroblasts/epithelial or epithelial/fibroblasts) to indicate the fold cell type preference or tropism 48 of each virus (Fig 2) . Both gH/gL/gO-rich viruses, TR and MT, were strongly fibroblast-tropic and some 49 heterologous gO isoforms enhanced this preference, while others reduced it. In contrast, the gH/gL/UL128-50 131-rich virus ME infected both cell type more equally (ratios closer to 1), and gO polymorphisms had little 51 effect. The limitation of any such measure of relative tropism is that it does not determine whether the virus in 52 question can efficiently infect one cell type in particular, both or neither. Thus, any 2 viruses compared may 53 have the same fibroblast-to-epithelial cell infectivity ratio for completely different reasons. To address this we 54 also compared infectivity on both cell types using a common comparison for all viruses, i.e., the number of 55 virions in the stock as determined by qPCR for DNAse-protected viral genomes in the cell-free virus stocks ( Fig   56   3 ). This analysis provided a measure of specific infectivity as the number of genomes/IU, where the lower ratio 57 indicates more efficient infection. Whether higher genomes/IU values reflect the presence of greater numbers 58 of bona fide "defective" virions, or a lower probability or efficiency of each viable virion in the stock to 59 accomplish a detectable infection, and whether or how these two possibilities are different is difficult to know 60 for any type of virus. Nevertheless, these analyses provided important insights to the tropism ratios reported.
61
In general, the specific infectivity ratios of the gH/gL/gO-rich viruses TR and MT in these experiments were in 62 the range of 500-5000 genomes/IU on fibroblasts, but these viruses were approximately 20-100 fold less 63 infectious on epithelial cells, explaining the strong fibroblast preference exhibited by these strains. The effect the change of gO affect the fundamental fibroblast preference of either TR or MT. The infectivity of the 68 gH/gL/UL128-131-rich, ME-based viruses on both cell types was undetectable in these assays. Thus, the near 69 neutral fibroblast-to-epithelial tropism ratios of the ME-based viruses seem to reflect an equal inability to infect 70 either cell type and any assertion of a "preference" for either cell type for extracellular ME virions seems 71 spurious.
72
Binding to PDGFR through gO is clearly critical for infection of fibroblasts (30). However, while 73 gH/gL/gO is also important for infection of epithelial cells, the literature is conflicted on the expression of 74 PDGFR and its importance for HCMV infection in epithelial and endothelial cells (26, 28, 29, 32, 33 (20, 32, 34) . It has also been shown 79 that gH/gL/gO engagement of PDFGR can elicit signaling cascades, but that this is not required for infection 80 (28, 30, 32) . In contrast, there is evidence that gH/gL/gO can help facilitate initial virion attachment (33, 54) . 81
In our studies, TNgO(GT4) reduced binding of TR to both fibroblasts and epithelial cells (Fig 4, Tables 2 and   82 3). However, the reduced binding of TR_TNgO(GT4) did not result in reduced infection of either cell type, and 83 there were other isoforms of gO that either resulted in increased or decreased infectivity but were not 84 associated with any detectable alteration in binding. Thus, while gH/gL/gO may contribute to initial binding, it is 85 likely involved in other important mechanisms that facilitate infection and these can be influenced by gO 86 polymorphisms. For example, it is possible that polymorphisms in gO can affect the nature and outcome of 87 PDGFR engagement. In support of this hypothesis, Stegmann et al. showed that mutation of conserved 88 residues within the N-terminal variable domain of gO were critical for PDGFR binding (60). Thus it is 89 conceivable that the variable residues of gO can alter the architecture of the interaction with PDGFR.
90
Alternatively, it may be that there are other receptors on both cell types for gH/gL/gO and that gO 91 polymorphisms can affect those interactions. Also, the effects of several specific gO isoforms observed in the 92 TR-background were not observed in the ME or MT-backgrounds. Possible explanations for the apparent 93 epistasis include not only the differential contributions of polymorphisms in gH/gL, but also potential differences partially explained by the non-infectious nature of cell-free ME virions (Fig 3) (27, 50, 51, 55) . Laib Sampaio et 99 al. showed that inactivation of the UL74(gO)ORF in ME did not impair spread but that a dual inactivation of 00 both gO and UL128 completely abrogated spread (27). This indicates that gH/gL/UL128-131 is sufficient for 01 cell-to-cell spread in fibroblasts or endothelial cells in the absence of gH/gL/gO, and it seems likely that spread 02 in epithelial cells might be similar in this respect. Our finding that various heterologous gO isoforms can 03 enhance or reduce spread of ME without affecting the cell-free infectivity strongly suggest that while 04 gH/gL/UL128-131 may be sufficient for cell-to-cell spread, gH/gL/gO can modulate or mediate the process, if 05 present in sufficient amounts. In the context of MT, where expression of gH/gL/UL128-131 is reduced to sub-06 detectable levels (26, 51) the virus gained cell-free spread capability, and yet some of the heterologous gO 07 isoforms had opposite effects on cell-free infectivity and spread (compare Fig 3C to 5D ). Similar 08 discorrelations between cell-free infectivity and spread were observed for the naturally gH/gL/gO-rich strain 09 TR, albeit with different heterologous gO isoforms involved. That gO polymorphisms can have opposite effects 10 on cell-free and cell-to-cell spread supports a hypothesis of mechanistic differences in how gH/gL/gO mediates 11 the two processes, and again these effects seem dependent on epistatic influences of the different genetic 12 backgrounds.
13
Beyond the roles of gH/gL/gO in replication, the complex is likely a significant target of neutralizing 14 antibodies, and therefore a valid candidate for vaccine design. Several groups have reported neutralizing 15 antibodies that react with epitopes contained on the gH/gL base of both gH/gL/UL128-131 and gH/gL/gO and 16 others that react to gO (35) (36) (37) (38) (39) (40) (41) (42) (43) . We found that changing the gO isoform can have dramatic effects on the 17 sensitivity to two anti-gH mAbs (Figs 9 and 10) . In the TR background on fibroblasts, both ADgO(GT1a) and 18 TNgO(GT4) conferred significant resistance to neutralization by 14-4b, which likely reacts to a discontinuous 19 epitope near the membrane proximal ectodomain of gH (35, 56) . TNgO(GT4) also conferred resistance to 20 AP86, which reacts to a linear epitope near the N-terminus of gH (57), whereas ADgO(GT1a) actually 21 increased sensitivity of TR to AP86. Neutralization by either antibody on epithelial cells was not significantly affected, consistent with the notion that these antibodies can also neutralize by reacting to gH/gL/UL128-131.
Again, the strain background exerted considerable influence over the effects of gO polymorphisms. For MT, it 24 was ADgO(GT1a) that conferred resistance to 14-4b, and the other isoforms had little or no effect. The 25 observed effects on neutralization on gH epitopes likely involve differences in how gO variable regions or 26 associated glycans fold onto gH/gL to exert differential steric effects. Relatedly, the differential influence of gO 27 isoforms in the two genetic backgrounds suggests epistasis involving the additive effects of gO polymorphisms 28 with the more subtle gH polymorphisms, which together can differentially affect the global conformation of the 29 gH/gL/gO trimer.
30
Previous analyses have suggested two groups of gH sequences defined by polymorphisms at the N-31 terminus, including the AP86 epitope (57, 61). Of the strains represented in this study, TB, TR and AD belong 32 to the gH1 genotype and are sensitive to AP86, whereas ME, TN and PH belong to gH2 genotype and are 33 resistant to AP86. The differential effects of gO recombinants reported here raise questions about the 34 combinations of gH and gO genotypes in HCMV circulating in human populations. The recently published 35 genome sequence datasets from clinical specimens have been collected with short-read sequencing 36 approaches, which allow sensitive detection of the various gH and gO genotypes within samples, but not the 37 combinations of the two ORFs on individual genomes (1, 3, 4, 6, 7). To address, this we analyzed 236 38 complete HCMV genome sequences of isolated strains and BAC clones in the NCBI database (Fig 11) .
39
Approximately half the sequences were gH1 and the other half gH2. ADgO(GT1a) and TBgO(GT1c) 40 genotypes were exclusively linked to gH1, whereas MEgO(GT5) was exclusively linked to gH2. Other gO 41 genotypes were found mixed with both gH genotypes, but in most cases, disproportionally with one of the gH 42 genotypes. These analyses agreed with Rasmussen et al who suggested a strong linkage between gH1 and 43 gO1 genotypes (note that their study predated the GT1a, 1, b, and 1c subdivisions) (10). Thus, it appears that 44 
48
it was worth noting that among the more striking effects reported were the loss of cell-free infectivity and 49 differential sensitivity to neutralization by gH antibodies of TR_ADgO(GT1a). Together, with the fact that TR In conclusion, we have shown that naturally occurring polymorphisms in the HCMV gO can have a 53 dramatic influence on significant aspects of HCMV biology including, cell-free and cell-to-cell spread, and 54 neutralization by anti-gH antibodies. These effects could not be explained by changes to the levels of gH/gL 55 complexes in the virion envelope, but rather point to changes in the mechanism(s) of gH/gL/gO in the 56 processes of cell-free and cell-to-cell spread. The associated epistasis with the global genetic background recombineering technique was performed (63, 64). In the first step, the endogenous UL74 ORF from the start 87 codon to the stop codon of both TR and ME was replaced by a selectable marker. This necessary step was 88 added to prevent formation of chimeric UL74 gene by internal recombination of the UL74 BAC sequence and marker (AmpR) cassette from the pUC18 plasmid flanked by sequences homologous to 50 bp upstream and Briefly, E. coli cultures were prepared for recombination as described above for step 1 and electroporated with 05 purified PCR products containing the UL74 ORF from the TR or ME strain flanked by sequence homologous to 06 50 bp upstream and downstream of the opposite strain. The UL74 ORF also contained an inserted En Passant 07 cassette (an I-SceI site followed by a kanamycin resistance gene surrounded by a 50-bp duplication of the 08 UL74 nucleotides of the insertion site). Transformed E. coli cells were induced for recombination and then 09 selected for the swap of the UL74 En Passant sequence into the BAC by growth on medium containing 10 kanamycin (50 µg/ml) and chloramphenicol (12.5 μg/ml). A PCR reaction analysis with primers located 11 upstream and downstream of UL74 was used to confirm the swap of the AmpR cassette by the En Passant 12 cassette/UL74 gene.
13
In the third step, several sequencing validated colonies of the second step were subjected to the last primers located upstream and downstream of the UL74 gene.
19
Antibodies. Monoclonal antibodies (MAbs) specific to HCMV major capsid protein (MCP), pp150, and 20 gH (14-4b and AP86) were provided by Bill Britt (University of Alabama, Birmingham, AL) (35, 57, 65, 66) . 14-21 4b and AP86 were purified by FPLC and quantified by the University of Montana Integrated Structural Biology
22
Core Facility. Rabbit polyclonal sera against HCMV gL was described previously (9, 26). 23
Immunoblotting. HCMV cell-free virions were solubilized in 2% SDS-20 mM Tris-buffered saline 24 (TBS) (pH 6.8). Insoluble material was cleared by centrifugation at 16,000 X g for 15min, and extracts were 25 then boiled for 10 min. For reducing blots, dithiothreitol (DTT) was added to extracts to a final concentration of 26 25 mM. After separation by SDS-PAGE, proteins were transferred onto polyvinylidene difluoride (PVDF) 27 membranes (Whatman) in a buffer containing 10 mM NaHCO 3 and 3mM Na 2 CO 3 (pH 9.9) plus 10% methanol.
28
Transferred proteins were probed with MAbs or rabbit polyclonal antibodies, anti-rabbit or anti-mouse 29 secondary antibodies conjugated with horseradish peroxidase (Sigma-Aldrich), and Pierce ECL-Western 30 blotting substrate (Thermo Fisher Scientific). Chemiluminescence was detected using a Bio-Rad ChemiDoc 31 MP imaging system. Band densities were quantified using BioRad Image Lab v 5.1.
32
Quantitative PCR. Viral genomes were determined as described previously (26). Briefly, cell-free 33 HCMV stocks were treated with DNase I before extraction of viral genomic DNA (PureLink viral RNA/DNA 34 minikit; Life Technologies/Thermo Fisher Scientific). Primers specific for sequences within UL83 were used 35 with the MyiQ real-time PCR detection system (Bio-Rad).
36
Flow cytometry. Recombinant GFP-expressing HCMV-infected cells were washed twice with PBS 37 and lifted with trypsin. Trypsin was quenched with DMEM containing 10% FBS and cells were collected at 500 38 g for 5 min at RT. Cells were fixed in PBS containing 2% paraformaldehyde for 10 min at RT, then washed 39 and resuspended in PBS. Samples were analyzed using an AttuneNxT flow cytometer. Cells were identified 40 using FSC-A and SSC-A, and single cells were gated using FSC-W and FSC-H. BL-1 laser (488nm) was used 41 to identify GFP+ cells, and only cells with median GFP intensities 10-fold above background were considered 42 positive.
43
Virus particle binding. nHDF or ARPE19 cells were seeded at density of 35,000 cells per cm 2 on 44 chamber slides (Nunc Lab Tek II). 2 days later, virus stocks were diluted with media to equal numbers of virus virus before fixation and permeabilization with 80% acetone for 5min. Bound virus particles were stained with 84:7195-7203.
6569.
derivative of platelet-derived growth factor receptor alpha binds to the trimer of human cytomegalovirus intracellular analogs of glycoprotein H of human cytomegalovirus. Arch Virol 126:67-80. 
97
HCMV TR, ME, MT or the corresponding heterologous gO recombinants were applied to nHDF for 20 min. acetone and cell-associated virus particles were detected by immunofluorescence using antibodies specific for binding in 3 independent experiments (Table 2) 
